A detailed history of State Street Corp transactions in Neogenomics Inc stock. As of the latest transaction made, State Street Corp holds 4,897,766 shares of NEO stock, worth $67.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,897,766
Previous 4,844,945 1.09%
Holding current value
$67.1 Million
Previous $78.4 Million 1.78%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$14.06 - $16.79 $742,663 - $886,864
52,821 Added 1.09%
4,897,766 $77 Million
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $928,278 - $1.65 Million
-79,544 Reduced 1.62%
4,844,945 $78.4 Million
Q3 2023

Nov 14, 2023

SELL
$12.15 - $17.85 $23,121 - $33,968
-1,903 Reduced 0.04%
4,924,489 $60.6 Million
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $567,130 - $797,602
40,222 Added 0.82%
4,926,392 $79.2 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $2.15 Million - $4.59 Million
236,236 Added 5.08%
4,886,170 $85.1 Million
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $2.79 Million - $5.22 Million
432,774 Added 10.26%
4,649,934 $43 Million
Q3 2022

Nov 15, 2022

BUY
$7.86 - $12.91 $918,063 - $1.51 Million
116,802 Added 2.85%
4,217,160 $36.3 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $996,836 - $1.97 Million
141,195 Added 3.57%
4,100,358 $33.4 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $1.83 Million - $5.31 Million
150,466 Added 3.95%
3,959,163 $48.1 Million
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $6.95 Million - $11.1 Million
227,955 Added 6.37%
3,808,697 $130 Million
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $3.8 Million - $4.79 Million
91,271 Added 2.62%
3,580,742 $173 Million
Q2 2021

Aug 16, 2021

BUY
$36.62 - $51.69 $6.96 Million - $9.83 Million
190,095 Added 5.76%
3,489,471 $158 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $5.96 Million - $8.59 Million
143,480 Added 4.55%
3,299,376 $159 Million
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $681,262 - $1.07 Million
18,882 Added 0.6%
3,155,896 $170 Million
Q3 2020

Nov 10, 2020

SELL
$33.26 - $40.48 $2.48 Million - $3.02 Million
-74,679 Reduced 2.33%
3,137,014 $116 Million
Q2 2020

Aug 14, 2020

BUY
$24.21 - $31.02 $4.94 Million - $6.33 Million
204,087 Added 6.79%
3,211,693 $99.5 Million
Q1 2020

May 11, 2020

BUY
$20.5 - $34.53 $61.7 Million - $104 Million
3,007,606 New
3,007,606 $83 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.72B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.